Core Viewpoint - Hanbang Technology experienced a slight decline in stock price, with a trading volume of 39.14 million yuan on October 29, 2023, indicating a net outflow in financing activities [1] Financing Summary - On October 29, Hanbang Technology had a financing buy-in amount of 2.85 million yuan and a financing repayment of 5.56 million yuan, resulting in a net financing buy-in of -2.71 million yuan [1] - As of October 29, the total financing and securities lending balance for Hanbang Technology was 77.34 million yuan, which accounts for 10.36% of its circulating market value [1] - There were no shares repaid or sold in the securities lending segment on the same day, with a remaining balance of 0.00 yuan [1] Business Performance Summary - As of September 30, 2023, Hanbang Technology had 8,687 shareholders, a decrease of 7.31% from the previous period, while the average circulating shares per person increased by 7.89% to 1,904 shares [2] - For the period from January to September 2023, Hanbang Technology reported a revenue of 506 million yuan, representing a year-on-year growth of 4.61%, while the net profit attributable to shareholders decreased by 17.27% to 37.02 million yuan [2] - Since its A-share listing, Hanbang Technology has distributed a total of 8.80 million yuan in dividends [2] Company Overview - Hanbang Technology, established on October 28, 1998, is located in Huai'an Economic and Technological Development Zone, Jiangsu Province, and specializes in providing separation and purification equipment, consumables, application technology services, and related technical solutions for the pharmaceutical and life sciences sectors [1] - The revenue composition of Hanbang Technology includes 70.99% from small molecule drug separation and purification equipment, 22.94% from large molecule drug separation and purification equipment, and 6.07% from other sources [1]
汉邦科技10月29日获融资买入285.01万元，融资余额7734.26万元